Characterization of a novel bile acid-based delivery platform for microencapsulated pancreatic β-cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Characterization of a novel bile acid-based delivery platform for microencapsulated pancreatic β-cells
Authors
Keywords
-
Journal
Artificial Cells Nanomedicine and Biotechnology
Volume 44, Issue 1, Pages 194-200
Publisher
Informa UK Limited
Online
2014-07-11
DOI
10.3109/21691401.2014.934457
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Stability and Release Kinetics of an Advanced Gliclazide-Cholic Acid Formulation: The Use of Artificial-Cell Microencapsulation in Slow Release Targeted Oral Delivery of Antidiabetics
- (2014) Armin Mooranian et al. Journal of Pharmaceutical Innovation
- Advances in biocompatibility and physico-chemical characterization of microspheres for cell encapsulation
- (2013) Anne Mari A. Rokstad et al. ADVANCED DRUG DELIVERY REVIEWS
- Type 2 Diabetes: Etiology and reversibility
- (2013) R. Taylor DIABETES CARE
- Islet encapsulation: advances and obstacles
- (2013) G. C. Weir DIABETOLOGIA
- Ursodeoxycholic Acid but Not Tauroursodeoxycholic Acid Inhibits Proliferation and Differentiation of Human Subcutaneous Adipocytes
- (2013) Lucia Mališová et al. PLoS One
- Deoxycholic Acid as a Modifier of the Permeation of Gliclazide through the Blood Brain Barrier of a Rat
- (2013) Mladena Lalić-Popović et al. Journal of Diabetes Research
- Diabetic β Cells: To Be or Not To Be?
- (2012) Sapna Puri et al. CELL
- Novel tamarind seed polysaccharide-alginate mucoadhesive microspheres for oral gliclazide delivery:in vitro–in vivoevaluation
- (2012) Dilipkumar Pal et al. DRUG DELIVERY
- Dose-dependent antiinflammatory effect of ursodeoxycholic acid in experimental colitis
- (2012) Patricia Martínez-Moya et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Development, Optimization, and Anti-diabetic Activity of Gliclazide-Loaded Alginate–Methyl Cellulose Mucoadhesive Microcapsules
- (2011) Dilipkumar Pal et al. AAPS PHARMSCITECH
- Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats
- (2011) Hani Al-Salami et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Immunoisolating semi-permeable membranes for cell encapsulation: Focus on hydrogels
- (2011) E.H. Nafea et al. JOURNAL OF CONTROLLED RELEASE
- Type 2 diabetes across generations: from pathophysiology to prevention and management
- (2011) Christopher J Nolan et al. LANCET
- The influence of 3α,7α-dihydroxy-12-keto-5β-cholanate on gliclazide pharmacokinetics and glucose levels in a rat model of diabetes
- (2010) Momir Mikov et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Gliclazide reduces MKC intestinal transport in healthy but not diabetic rats
- (2010) Hani Al-Salami et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Bile salt-reinforced alginate-chitosan beads
- (2010) Sevgi Takka et al. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- Influence of the semisynthetic bile acid MKC on the ileal permeation of gliclazide in vitro in healthy and diabetic rats treated with probiotics
- (2009) H. Al-Salami et al. METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
- Toward a cell-based cure for diabetes: advances in production and transplant of beta cells
- (2008) Kathryn C. Claiborn et al. MOUNT SINAI JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started